Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Huang Dennis Karl
See Remarks at Ultragenyx Pharmaceutical. Filing since 14 Oct 2020.
CIK 0001641217
Company
Date
Role
Action
Shares
Amount
Of holding
RARE
Ultragenyx Pharmaceutical Inc.
1 Mar 2023
See Remarks
Sold, plan not stated
389
$17.76K
0.5%
RARE
Ultragenyx Pharmaceutical Inc.
1 Mar 2022
See Remarks
Sold, plan not stated
3,234
$215.45K
8.1%
RARE
Ultragenyx Pharmaceutical Inc.
14 Oct 2021
EVP & Chief Tech Ops Officer
Sold, plan not stated
358
$29.05K
0.9%
RARE
Ultragenyx Pharmaceutical Inc.
6 May 2021
EVP & Chief Tech Ops Officer
Sold, plan not stated
363
$41.27K
0.9%
RARE
Ultragenyx Pharmaceutical Inc.
1 Mar 2021
EVP & Chief Tech Ops Officer
Sold, plan not stated
4,255
$587.96K
9.5%
RARE
Ultragenyx Pharmaceutical Inc.
14 Oct 2020
EVP & Chief Tech Ops Officer
Sold, plan not stated
262
$23.06K
0.7%
6 decisions on file.
